2,929
Views
7
CrossRef citations to date
0
Altmetric
Report

Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency

, , , , , , , , , , , , , , , , , , , , , , , , , , & ORCID Icon show all
Article: 2165390 | Received 21 Sep 2022, Accepted 30 Dec 2022, Published online: 02 Feb 2023